A partnership with J&J’s Janssen Pharmaceuticals is helping PhysIQ advance with its device-agnostic clinical data collection and analysis platform. Over the course of the last year and some change, the impact of digital health and the need for it has increased by an immeasurable amount. Virtual care became the norm after the COVID-19 pandemic hit, […]
physiq
PhysIQ, Janssen partner on digital therapeutics
PhysIQ announced today that it is collaborating to license its AccelerateIQTM platform with Janssen Pharmaceuticals. Chicago-based PhysIQ’s AccelerateIQTM will be licensed to Janssen, a Johnson & Johnson unit so it can deploy it to collect data across its clinical studies through a range of its wearable biosensors, while also utilizing PhysIQ’s portfolio of FDA-cleared digital […]
PhysIQ hires Scripps Research Translational Institute doctor as chief medical officer
PhysIQ announced today that it appointed the Scripps Research Translational Institute digital medicine director as its chief medical officer. Dr. Steve Steinhubl will remain with SRTI, where he’s been the director of digital medicine for more than seven years, while he takes on his new role at PhysIQ as he looks to help advance the […]
NIH increases PhysIQ contract to $6.6M
PhysIQ announced today that the National Institutes of Health (NIH) entered into Phase II of a contract for its AI-based COVID-19 biomarker. A Purdue University-affiliated artificial intelligence company, PhysIQ’s AI-based COVID-19 digital biomarker is being developed to address the rapid decompensation of high-risk COVID-19 patients, according to a news release. PhysIQ’s technology’s cloud platform continuously […]
NIH awards contracts to develop digital health technologies for COVID-19
The National Institutes of Health announced that it awarded seven contracts to companies to develop digital health solutions for addressing COVID-19. NIH said in a news release that the technology developed to help address the pandemic could lead to user-friendly tools like smartphone apps, wearable devices and software that can identify and trace contacts of […]
PhysIQ touts VA study showing AI predicting hospitalizations
PhysIQ today is touting results from a study testing the ability to detect heart failure exacerbation using wearable sensors and personalized analytics based on artificial intelligence. The Link-HF study set out to assess the ability to predict rehospitalization due to heart failure exacerbation using analytics applied to continuous wearable sensor data, according to a news […]
PhysIQ raises $6m for its AI for wearable insights
Purdue University-affiliated artificial intelligence company PhysIQ has reaised $6 million in equity, according to an amended SEC Form D. West Lafayette, Ind.-based PhysIQ listed the first sale of the amended equity offering as occurring on Nov. 15, 2019. The company does not intend for the offering to last for more than one year, according to […]
PhysIQ awarded $500,000 for AI research
PhysIQ, a Purdue University-affiliated artificial intelligence company, announced today that it received a $500,000 investment from the Purdue Research Foundation’s Foundry Investment Fund to help the company advance its medical technology. West Lafayette, Ind.–based PhysIQ develops healthcare solutions by applying AI to real-time physiological data from wearable sensors. The company’s FDA-cleared technology is designed to […]
Study: Wearable AI-powered biosensors show promise for HF detection
Wearable biosenors with artificial intelligence-based analytics can provide accurate early detection of impending rehospitalization similar to implanted devices, according to data from a new study backed by the US Dept. of Veterans Affairs. The trial explored the ability of wearable sensors, developed by VitalConnect, supported by AI-driven analytics, developed by PhysIQ, to effectively predict heart […]
